Zar N, Holmberg L, Wilander E, Rastad J
Department of Surgery, University Hospital, Uppsala, Sweden.
Eur J Cancer. 1996 Nov;32A(12):2114-9. doi: 10.1016/s0959-8049(96)00244-4.
All cases of adenocarcinoma in the duodenum (n = 263) and jejunum/ileum (n = 663), diagnosed between 1960 and 1988, were recruited from the Swedish Cancer Registry. Corrected and overall survival were investigated by sex, age and year of diagnosis with life-table and Cox proportional hazards analyses. The corrected 5- and 10-year survival rates were 39% and 37% for duodenal tumours and 46% and 41% for those in jejunum/ileum (P = 0.16 for difference between sites). The corrected 5- and 10-year survival rates were 52% and 48% for women and 40% and 34% for men with tumours in jejunum/ileum (P = 0.0095 for difference by sex) while no such relation was found in duodenal tumours (P = 0.84). Survival correlated with age at diagnosis for duodenal tumours (P = 0.03377). A Cox proportional hazards analysis revealed a temporal trend with more favourable prognosis in recent years. This study confirms that prognosis of small bowel adenocarcinoma is serious, but gives a more optimistic outlook than many hitherto published series.
1960年至1988年间确诊的所有十二指肠腺癌病例(n = 263)和空肠/回肠腺癌病例(n = 663)均来自瑞典癌症登记处。通过寿命表和Cox比例风险分析,按性别、年龄和诊断年份对校正生存率和总生存率进行了调查。十二指肠肿瘤校正后的5年和10年生存率分别为39%和37%,空肠/回肠肿瘤的校正后5年和10年生存率分别为46%和41%(部位间差异P = 0.16)。空肠/回肠肿瘤女性的校正后5年和10年生存率分别为52%和48%,男性为40%和34%(性别差异P = 0.0095),而十二指肠肿瘤未发现这种关系(P = 0.84)。十二指肠肿瘤的生存率与诊断时的年龄相关(P = 0.03377)。Cox比例风险分析显示近年来预后有更有利的时间趋势。本研究证实小肠腺癌的预后严重,但比许多迄今发表的系列研究给出了更乐观的前景。